Evidence map›Paper›PMID 24032529›Full record

ArticleBritish journal of pharmacology2013

The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats.

A H Altamirano-Espinoza, A González-Hernández, G Manrique-Maldonado, B A Marichal-Cancino, I Ruiz-Salinas, C M Villalón

Abstract read
In one paragraph

Article in British journal of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Dopamine Pharmacodynamics: New Insights.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Dopamine DPflugers Archiv : European journal of physiology · 2020
    Article
  4. The role of purinergic P2YPurinergic signalling · 2020
    Article
  5. Review
  6. Article
  7. The role of αThe journal of headache and pain · 2017
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

A H Altamirano-EspinozaDepartamento de Farmacobiología, Cinvestav-Coapa, México D.F., México.
A González-Hernández
G Manrique-Maldonado
B A Marichal-Cancino
I Ruiz-Salinas
C M Villalón

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeQuinpirole (a dopamine D2-like receptor agonist) inhibits the cardioaccelerator sympathetic outflow in pithed rats by sympathoinhibitory D2-like receptors. The present study was designed to identify pharmacologically the specific D2-like receptor subtypes (i.e. D2 , D3 and D4) involved in this sympathoinhibition by quinpirole. EXPERIMENTAL APPROACH: One hundred fourteen male Wistar rats were pithed, artificially ventilated with room air and prepared for either preganglionic spinal (C7-T1) stimulation of the cardioaccelerator sympathetic outflow (n = 102) or i.v. bolus injections of exogenous noradrenaline (n = 12). This approach resulted in frequency-dependent and dose-dependent tachycardic responses, respectively, as previously reported by our group. KEY

resultsI.v. continuous infusions of quinpirole (0.1-10 μg kg(-1)  min(-1)), but not of saline (0.02 mL min(-1)), dose-dependently inhibited the sympathetically induced tachycardic responses. Moreover, the cardiac sympathoinhibition induced by 3 μg kg(-1)  min(-1) quinpirole (which failed to affect the tachycardic responses to i.v. noradrenaline) was: (i) unchanged after i.v. injections of the antagonists SB-277011-A (D3 ; 100-300 μg kg(-1)) or L-745,870 (D4 ; 30-100 μg kg(-1)); and (ii) markedly blocked and abolished by, respectively, 100 and 300 μg kg(-1) of the D2 preferring receptor subtype antagonist L-741,626. These doses of antagonists, which did not affect per se the sympathetically induced tachycardic responses, were high enough to completely block their respective receptors. CONCLUSIONS AND IMPLICATIONS: The cardiac sympathoinhibition induced by 3 μg kg(-1)  min(-1) quinpirole involves the dopamine D2 receptor subtype, with no evidence for the involvement of the D3 or D4 subtypes. This provides new evidence for understanding the modulation of the cardioaccelerator sympathetic outflow.

Indexed as

AnimalsDecerebrate StateDopamine AgonistsDopamine AntagonistsDose-Response Relationship, DrugElectric StimulationHeartHeart RateInfusions, IntravenousInjections, IntravenousMaleNorepinephrineQuinpiroleRatsRats, WistarReceptors, Dopamine D2Dopamine AgonistsDopamine AntagonistsDrd3 protein, ratDrd4 protein, ratNorepinephrineQuinpiroleReceptors, Dopamine D2Receptors, Dopamine D3Receptors, Dopamine D4Sympathomimeticscardioaccelerator sympathetic outflowdopamine D2-like receptorsL-741,626L-745,870SB-277011-Asympathoinhibitiontachycardic responses

Identifiers

PMID24032529
PMCPMC3949657

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.